SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-057090
Filing Date
2015-08-06
Accepted
2015-08-06 14:53:30
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-11951_110q.htm 10-Q 1019870
2 EX-31.1 a15-11951_1ex31d1.htm EX-31.1 11317
3 EX-31.2 a15-11951_1ex31d2.htm EX-31.2 11801
4 EX-32 a15-11951_1ex32.htm EX-32 9733
  Complete submission text file 0001104659-15-057090.txt   5081145

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT thrx-20150630.xml EX-101.INS 1120748
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20150630.xsd EX-101.SCH 45262
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20150630_cal.xml EX-101.CAL 53987
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20150630_lab.xml EX-101.LAB 416516
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20150630_pre.xml EX-101.PRE 289074
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20150630_def.xml EX-101.DEF 156129
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 151032610
SIC: 2834 Pharmaceutical Preparations